A multi-omics pipeline integrating machine learning and spatial-cellular analysis identifies SASH1 as a prognostic biomarker and therapeutic target in head and neck squamous cell carcinoma.

Int J Surg · 2025 · PMC12695206 · PMID 41099090

Europe PMC DOI

hedged sentence

0.0463

closest p · 0.9× alpha

0.0463

boldest claim

The sentences

showed a trendP = 0.0463actually significant

SASH1 expression showed a trend toward association with prognosis ( P = 0.0463), with the low-expression group exhibiting lower survival probability, suggesting SASH1 as a potential favorable prognostic marker, though further validation is needed.

also in 28,865 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.